ong-term safety study of KRP-AB1102
Phase 3
- Conditions
- COPD
- Registration Number
- JPRN-jRCT2080221930
- Lead Sponsor
- Kyorin Pharmaceutical Co.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Adult male or female COPD patients aged >= 40, and others.
Exclusion Criteria
- History or current diagnosis of asthma
- Patient changed drug treatment for COPD within 4 weeks prior to screening visit, and others.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method